Table 2.
1–12 months | 13–60 months | > 60 months | |
---|---|---|---|
Amikacin | – | – | 0.6 |
Gentamicin | 11.3 | 12.8 | 5.7 |
Ciprofloxacin | 8.3 | 7.1 | 8.2 |
Cefuroxime | 27.3 | 32.5 | 23.1 |
Ceftazidime | 4.5 | 15.8 | 13.3 |
Ceftriaxone | 2.1 | 5.0 | 1.5 |
Cephalotin | 46.2 | 47.3 | 41.8 |
Ampicillin | 56.3 | 57.7 | 61.6 |
TMP-SMXa | 30.7 | 31.4 | 32.7 |
Nitrofuratoin | 6.7 | 3.9 | 3.9 |
Amoxicillinclavulanate | 16.1 | 17.9 | 13.9 |
The resistance rates exceeding 20% were in boldface
-= No resistance
*= trimethoprim-sulfometaxazole